About Us

We are passionate about the use of science and computational intelligence to push the boundaries of medical understanding and diagnostics.  We aim to become a trusted provider of responsible and clinically validated tools to improve healthcare worldwide for early diagnosis, better disease treatment, and equal access to the best medical advice.

Founder

With over 130 peer-reviewed publications in journals including Nature and the Royal Society, and multiple granted patents in the medical device space, our founder, Dr Hector Zenil, has contributed to the development of methods in optimal inference theory and their applications to scientific discovery, computational medicine, and systems biology, in particular to blood, cellular, and molecular biology.

Dr Hector Zenil is a pioneer in Algorithmic Information Dynamics, a framework that treats biological systems as evolving computational processes that can be algorithmically analysed, decoded, and reprogrammed.

His work builds on Algorithmic Probability, a formal foundation underpinning modern artificial intelligence founded by Gregory Chaitin who described Dr. Zenil as a “new kind of practical theoretician” during his PhD defence thesis, also publicly commending his work.

For over two decades, Dr Zenil has maintained a long-standing collaboration with Stephen Wolfram, a central figure in modern computation and AI. After Wolfram’s early mentorship in the mid-2000s, he was appointed Senior Research Fellow at Wolfram’s personal Think Tank in Boston. He later was entrusted by Wolfram to serve as the Managing Editor of his journal Complex Systems, the first in the field, founded by Wolfram in 1987.

Dr Zenil contributed to computational systems and functions associated with Mathematica and worked on projects in computational linguistics connected to code used by systems such as Siri, Alexa, and OpenAI’s first official plugin. Wolfram has continued to reference Dr Zenil’s work in his own writings (P vs. NP and the Difficulty of Computation).

Dr Zenil’s scientific trajectory is further reflected in his association with leading figures in theoretical physics. Sir Roger Penrose, Nobel Laureate in Physics (2020), wrote a foreword to his work, commenting on his contributions.

By synthesising Gregory Chaitin’s work on information theory and algorithmic complexity with Stephen Wolfram’s computational universe approach, Dr Zenil has moved these elite theories out of the intellectual "ivory tower" into the clinic.

As the architect of the Algocyte® platform, he has translated the abstract "It from Bit" doctrine into a cutting-edge precision medicine solution. By replacing the "black box" approach of traditional AI with transparent, algorithmic causal discovery.

Research

The team exploits its research experience carried out at top-ranked institutions at the forefront of AI and medicine, including Oxford, Cambridge, KCL and the Karolinska Institute, the institute that awards the Nobel Prize in Medicine or Physiology, by combining it with their experience in industry at leaders of computational intelligence and medical device innovation.

Our founder and team leaders have published over 300 papers in all the top-ranked journals in the areas of Artificial Intelligence, precision medicine, and systems immunology.

Integrative Teams

Our cross-disciplinary team consists of AI experts, medical leaders, and pioneers in IoT and engineering working at the forefront of science and technology. With our multidisciplinary approach, we tackle some of the most pressing human health challenges, such as infection, cancer, antibiotic resistance, and tropical diseases from a technological and commercial-viability point of view.

Our Team

AI diagnostics for healthcare providers and individuals – #Algocyte #AGI #CausalAI #PredictiveMedicine #OxfordImmuneAlgorithmics

Dr. Hector Zenil

Founder and Chief Executive Visionary Officer

Ph.D. in Computer Science (Lille) & Ph.D. in Logic (Paris Sorbonne). Associate Professor in Bio and Healthcare Engineering at King’s College London. Former lab leader & senior researcher affiliated with five of the world’s top universities in AI (Cambridge, Oxford, MIT, CMU) & Medicine (Karolinska). He wrote code behind Siri, Alexa, and ChatGPT that deals with factual contextual questions. He was a Payload team member for the NASA Mars Biosatellite project at MIT. He is a board and advisor member of multiple startups around the world.

Read more

Transforming healthcare through AGI-powered immune system insights – #FutureOfHealth #DigitalDiagnostics #Algocyte #OxfordImmuneAlgorithmics

Pamela Winsor

Strategic Advisor
(former Board Chair)

eMBA (2000) at St. Mary’s University, Halifax and the ICD.D (2015) with Rotman School of Business, Toronto. 20+ years as a Senior Healthcare Executive, including 14 years at Medtronic as CMO, the world largest medical device manufacturer. Member of the Canadian College of Health Leaders, and a leader visionary in patient-centric healthcare. Rotman, Judy Project Alumni and an executive coach.

Read more

Transforming healthcare through AGI-powered immune system insights – #FutureOfHealth #DigitalDiagnostics #Algocyte #OxfordImmuneAlgorithmics

Allan Bezanson

Director

Director of several public and private companies. He has a background in private equity & financial services with a demonstrated history of successfully building businesses as a leader and investor. Notable past successes Nowsco, Altus, Bluewave Energy, FCF Capital, Polaris, and Voxtur.

Read more

Transforming healthcare through AGI-powered immune system insights – #FutureOfHealth #DigitalDiagnostics #Algocyte

Abel Archundia

Advisor

Former Head of Digital Transformation and IT for Bayer Pharmaceuticals. He is a member of the group’s Digital Transformation Board as well as a member of the Bayer Group IT board. Former Global Head, Novartis TechOps/QA IT and Sandoz Division IT of Novartis. Former supply chain manager for Dell and as General Manager (US$500M business) on the vendor side. Chief Information Officer with broad experience (geo, functional & business), especially in large-scale transformation efforts (PMIs, IT Transformation, process governance).

Transforming healthcare through AGI-powered immune system insights – #FutureOfHealth #DigitalDiagnostics #Algocyte #OxfordImmuneAlgorithmics

John Cullen

Board Chair

Current CEO of JHI Associates. 30+ years experience in public company financing, corporate/capital structuring and management 20+ years corporate experience in the energy sector. Founded a number of public international resource companies following 15 years in the Canadian investment industry.

Read more

Transforming healthcare through AGI-powered immune system insights – #FutureOfHealth #DigitalDiagnostics #Algocyte #OxfordImmuneAlgorithmics

Prof. Jesper N. Tegnér

Director

Ph.D. in neurosciences (Karolinska). Professor of Bioscience and Computer Science (KAUST) specialised in AI applied to systems medicine and single-cell genomics. Founder of award-winning startups in Sweden. Chaired full professorship in Computational Biology, the first of its kind in Sweden and Strategic chaired full professor in Computational Medicine, Karolinska Institutet & Division of Clinical Epidemiology, Karolinska Hospital.

Read more

Remote AI-powered blood testing – #Algocyte #AGI #PreventiveCare #ImmuneMonitoring #DigitalHealth #OxfordImmuneAlgorithmics

Dr. Roger Ferguson, Jr.

Observer

J.D., and a Ph.D. in economics (Harvard). He has a significant stake in OIA as the second-largest individual shareholder after the Founder. Past President and CEO of TIAA, a Fortune 100 financial services organization. Former head of financial services for Swiss Re and Chairman of Swiss Re America Holding Corporation. Former Vice Chairman of the Board of Governors of the U.S. Federal Reserve. He serves on the boards of Alphabet, Inc. and on the boards of the Institute for Advanced Study, and Memorial Sloan Kettering Cancer Center, among others.

Read more

Dr. Pradip Banerjee

Director

A visionary C-Suite leader, seasoned board director, and serial venture creator with 30+ years of experience in building, scaling, and exiting companies across life sciences, SaaS, and healthcare technology. He served as Chairman & CEO of Xybion Digital Inc., where he transformed a $4M niche SaaS provider into a global market leader serving 350+ enterprise clients across 35 countries and a landmark 40X+ MOIC exit. During his career, as Founding Managing Partner at Accenture, he launched and scaled the firm’s Life Sciences R&D consulting business into a $1B global unit.

LinkedIn

Superintelligent health tracking for early intervention – #PreventSuffering #RemoteCare #ImmuneHealth #AGI

Prof. Kourosh Saeb-Parsy

Chief Medical Officer

MD & PhD in (neurosciences). Professor in Transplantation, group leader, Department of Surgery, Cambridge University. NHS Consultant Transplant Surgeon. Specialises in immunogenicity of cancer and regenerative cellular therapies. Multiple experience leading start-ups to success.

Read more

Remote AI-powered blood testing – #Algocyte #AGI #PreventiveCare #ImmuneMonitoring #DigitalHealth

Prof. Petter Brodin

Garfield Weston Chair & Professor of Paediatric Immunology (Imperial College) & Professor of Paediatric immunology (Karolinska Institutet). Develops novel methods to describe human immune system variation

Read more

Black-and-white portrait of a man wearing glasses, with short dark hair and a slight smile.

Dr. Sam Toney

Chief Medical Officer of Carespan has over thirty years of clinical management experience in health plan populations including Medicare, Medicaid, Tricare and commercial lines of business. Frequent speaker at Medicaid Managed Care Congress and Medicaid Health Plans of America Conference, and has presented on national webinars for Health Plan Alliance

Read more

Dr. Rolf Porsche

Physician, healthcare strategist, and innovation leader. He has served in senior roles including at IBM Global Business Services as Partner and Head of Healthcare Consulting, where he drove strategic initiatives at the interface of medicine and technology. He has supported, managed and drove projects achieving an overall revenue of over €100 billion.

Remote AI-powered blood testing – #Algocyte #AGI #PreventiveCare #ImmuneMonitoring #DigitalHealth

Prof. Patrick Tighe

Professor of Molecular Immunology (Nottingham) specialised in molecular cloning, T cell receptor analysis, fluorescent detection technologies & immunoassay tech.

Read more

Remote AI-powered blood testing – #Algocyte #AGI #PreventiveCare #ImmuneMonitoring #DigitalHealth

Dr. Jason Berman

Full Professor of Paediatrics and Cellular & Molecular Medicine at the University of Ottawa. Clinician, researcher and thought leader. Serves as CEO & Scientific Director of the Children’s Hospital of Eastern Ontario (CHEO).

Read more

Causal diagnostics using artificial general intelligence – #BloodAnalysis #AGI #PrecisionMedicine #HealthTech

Dr. Corey Cutler

MD, MPH, FRCP(C) is the Medical Director of the Stem Cell Transplantation Program at the Dana-Farber Cancer Institute & an Associate Professor of Medicine at Harvard Medical School. Author of 300+ publications and 40 reviews and book chapters.

Read more

Causal diagnostics using artificial general intelligence – #BloodAnalysis #AGI #PrecisionMedicine #HealthTech

​Dr. Narsis A. Kiani

Lab leader and senior researcher at the Department of Oncology-Pathology and the Algorithmic Dynamics Lab, Karolinska Institute. BEng in medical engineering and a BSc in pure mathematics, MSc, and PhD in applied mathematics. She was a VINNMER (Vinnova-Marie curie) Fellow.

Read more

Causal diagnostics using artificial general intelligence – #BloodAnalysis #AGI #PrecisionMedicine #HealthTech

Tony Cambridge

Tony Cambridge is the Managing Director of Thornhill Healthcare Events & Consultancy, and Lead Biomedical Scientist in the Pathology Management team of a major trauma centre and acute care NHS hospital in England. With over 25 years’ experience in pathology & diagnostics.

Read more

Causal diagnostics using artificial general intelligence – #BloodAnalysis #AGI #PrecisionMedicine #HealthTech

Prof. Weizi Li

Associate Professor of Informatics & Digital Health, Deputy Director in Informatics Research Centre, Henley Business School, University of Reading. Principal Investigator of the EPSRC project on the ‘Future blood testing for inclusive monitoring and personalised analytics Network+’.

Read more

Causal diagnostics using artificial general intelligence – #BloodAnalysis #AGI #PrecisionMedicine #HealthTech

Martin Korbmacher

Founder and Managing Partner of Event Horizon Capital & Advisory GmbH. Event Horizon is a Corporate Finance Boutique as well as an investment vehicle. He holds the position of Chairman of the supervisory board of the publicly listed flatexDEGIRO AG, and is also Chairman of the supervisory board of the publicly listed SGT Private Equity GmbH & Co. KGaA.

Read more

Black and white portrait of a man in a suit and tie

Rembert de Villa

Has held leadership roles at EXL Healthcare, Mastercard, and Capgemini. He serves on several boards, including Carespan and the Joseph Brant Hospital Foundation

Read more

Causal diagnostics using artificial general intelligence – #BloodAnalysis #AGI #PrecisionMedicine #HealthTech

Dr. Syed Ahsan Raza

Senior Clinical Scientist at the Trauma and Transfusion Medicine Research Center, University of Pittsburgh, with expertise spanning from epidemiology (Ph.D.), to infection disease, big data analytics, clinical adaptive trials, Bayesian analysis, and AI. Former researcher (cancer) at Baylor College of Medicine from where he received his MD followed by postgraduate studies at Harvard. Over 50 peer-reviewed publications.

Read More

Causal diagnostics using artificial general intelligence – #BloodAnalysis #AGI #PrecisionMedicine #HealthTech

Dr. Andrew King

Consultant haematologist and clinical lead for haemato-oncology at Cambridge University Hospitals NHS Foundation Trust. Specialised in acute leukaemia, myeloma and bone marrow, transplantation/cellular therapy. Principal or sub-investigator on several late phase clinical trials. DPhil in molecular biology at the Weatherall Institute, University of Oxford. Co-author of Lecture Notes in Haematology.

Causal diagnostics using artificial general intelligence – #BloodAnalysis #AGI #PrecisionMedicine #HealthTech

Dr. Hamid Sadri

Hamid Sadri is the Director of Policy, Health Economics & Outcomes Research at Medtronic ULC. Holds a doctorate in clinical pharmacy and two graduate degrees, in health economics and healthcare management respectively, from the University of Toronto. He is is a registered pharmacist in Ontario and is a member of the
Canadian College of Health Leaders.

Read more

OIA Centres

Headquartered outside London in the UK & operating in several countries.

 

Oxford Immune Algorithmics Ltd
Davidson House, Forbury Square, RG1, 3EU, Reading UK

Registered Address

Oxford Immune Algorithmics Ltd
6 Richfield Place, 12 Richfield Avenue
RG1 8EQ, Reading
UK

Global HQs & Biolab

Commercial

AI Center
Immune Algorithmics Middle
East. PO Box: 46617, 15th Floor, WeWork Hub71
Abu Dhabi, UAE

OIA France
8 Avenue des Champs-Élysées
75008 Paris
France

Commercial


Algocyte Canada
130 Adelaide Street West, Suite 3002 Toronto, ON
Canada M5H 3P5